Why the study?
Polyvascular disease affects up to 20% of atherosclerotic patients and confers high cardiovascular risk, presenting complex medical management challenges in severe hypertension, extensive atherosclerosis, and renal disease.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Highlights the complex medical and surgical management of severe polyvascular disease, refractory hypertension, and renal disease in a single patient.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Weiss et al. (2022) conducted a case report in Refractory hypertension, polyvascular disease, chronic renal disease (n=1). Multimodal imaging and medical management was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: